Literature DB >> 29278281

Empiric antibiotics for community-acquired pneumonia: A macrolide and a beta-lactam please!

Grant Waterer1.   

Abstract

Entities:  

Keywords:  outcomes; resistance; respiratory infections

Mesh：

Substances：

Year:  2017        PMID： 29278281     DOI： 10.1111/resp.13248

Source DB:  PubMed          Journal:  Respirology        ISSN： 1323-7799            Impact factor:   6.424


× No keyword cloud information.
  5 in total

Review 1.  Contemporary Concise Review 2018: Respiratory infections and tuberculosis.

Authors:  David S Hui; Chi-Chiu Leung
Journal:  Respirology       Date:  2019-03-30       Impact factor: 6.424

2.  Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis.

Authors:  Catia Cilloniz; Raúl Mendez; Héctor Peroni; Carolina Garcia-Vidal; Verónica Rico; Albert Gabarrus; Rosario Menéndez; Antoni Torres; Alex Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-11-12       Impact factor: 3.267

Review 3.  Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia.

Authors:  Ronald Anderson; Jan G Nel; Charles Feldman
Journal:  Int J Mol Sci       Date:  2018-04-11       Impact factor: 5.923

Review 4.  Appropriate antibiotic management of bacterial lower respiratory tract infections.

Authors:  Charles Feldman; Guy Richards
Journal:  F1000Res       Date:  2018-07-23

Review 5.  Hot topics and current controversies in community-acquired pneumonia.

Authors:  Diego Severiche-Bueno; Daniela Parra-Tanoux; Luis F Reyes; Grant W Waterer
Journal:  Breathe (Sheff)       Date:  2019-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.